BB's Stock Haven

[jaybird249]

Why DXAX $2 + next week:
I thought you'd be interested in this; as I'm sure you're aware, DVAX is awaiting notification to find out if Heplisav will have the clinical hold removed by the FDA or perhaps even be granted FDA approval. What's tricky is figuring out just when that will be. DVAX has been stating, in their last few releases that they expect this issue to be resolved in the first half of 2009. The FDA Advisory Committee meets quarterly. So when is their next meeting?

May 20-21, 2009. Merry Christmas
http://www.fda.gov/cber/advisory/vrbp/vrbpmain.htm